Last update:

Arthritis & Rheumatism news

Arthritis & Rheumatism

New safety checklist aims to prevent side effects in patients with arthritis

Inappropriate prescription of an antirheumatic drug for an unsuitable patient can lead to severe side effects such as intestinal perforations, blood clots, heart failure, or liver damage.

Arthritis & Rheumatism

New prediction model could help inform patients of their risks of having shoulder replacement surgery

A new model to predict the risk of serious complications after shoulder replacement surgery has been developed in a collaboration between researchers from the University of Oxford, University of Bristol, and University of ...

Diseases, Conditions, Syndromes

Arthritis drugs may relieve long COVID lung symptoms

University of Virginia School of Medicine researchers have identified a potential treatment for the respiratory symptoms of long COVID after discovering an unknown cause of the condition inside the lungs.

Arthritis & Rheumatism

Video: Reducing thumb arthritis pain

Thousands of Americans suffer from thumb arthritis. This disorder can greatly affect daily life and can make it a struggle to do simple things like opening doors or holding objects.

Arthritis & Rheumatism

Link found between kneecap shape and debilitating joint disease

The shape of a person's kneecap could be an indicator of whether they're more at risk of developing osteoarthritis, according to a new study from The Australian National University (ANU) published in Osteoarthritis and Cartilage.

Arthritis & Rheumatism

Air pollution may affect lupus risk

New research published in Arthritis & Rheumatology indicates that chronic exposure to air pollutants may increase the risk of developing lupus, an autoimmune disease that affects multiple organs.

Arthritis & Rheumatism

World's first CAR-T cell therapy for a child with lupus

In June 2023, Uresa A. (who was 15 years old at the time) received CAR-T cells at Universitätsklinikum Erlangen. The treatment was the last resort to slow down systemic lupus erythematosus (SLE), which is a serious autoimmune ...

Arthritis & Rheumatism

FDA expands pediatric indication for Rinvoq

The U.S. Food and Drug Administration has expanded indications for AbbVie's Rinvoq (upadacitinib) to now include pediatric patients (ages 2 years and older) with polyarticular juvenile idiopathic arthritis (pJIA) and psoriatic ...